Article info

Download PDFPDF
Primary chemoprevention of endometrial hyperplasia with the peroxisome proliferator-activated receptor gamma agonist rosiglitazone in the PTEN heterozygote murine model

Authors

  1. Address correspondence and reprint requests to: Karen H. Lu, MD, Department of Gynecologic Oncology, The University of Texas M.D. Anderson Cancer Center, 1155 Herman P. Pressler Street, Houston, TX 77030, USA. Email: khlu{at}mdanderson.org

Citation

Wu W, Celestino J, Milam MR, et al
Primary chemoprevention of endometrial hyperplasia with the peroxisome proliferator-activated receptor gamma agonist rosiglitazone in the PTEN heterozygote murine model

Publication history

  • First published February 1, 2008.
Online issue publication 
February 01, 2008

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.